Nationwide Children's Events & Announcements

Mar 28, 2022

Nationwide Children’s Hospital Once Again Earns Highest Ranking from Human Rights Campaign for Inclusive Care and Employment Practices

Nationwide Children’s Hospital has once again earned the “LGBTQ+ Health Care Equality Leader” (HEI) designation from the Human Rights Campaign Foundation (HRC) for its successful commitment to being both an inclusive health care provider and employer.

Mar 23, 2022

Nationwide Children’s Hospital Selected as Clinical Coordinating Center in Large National Clinical Trial Sponsored by National Heart Lung and Blood Institute (NHLBI)

The National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has announced that Nationwide Children’s Hospital has been selected for funding as the Clinical Coordinating Center for the multicenter randomized trial: “Percutaneous intervention versus observational trial of arterial ductus in lower gestational age infants (PIVOTAL)”.

Catherine Krawczeski, MD, Named Chief of the Department of Pediatrics at Nationwide Children’s Hospital
Mar 15, 2022

Catherine Krawczeski, MD, Named Chief of the Department of Pediatrics at Nationwide Children’s Hospital

Catherine Dent Krawczeski, MD, has been named Physician-in-Chief and Chief of the Department of Pediatrics at Nationwide Children’s Hospital. Dr. Krawczeski will also serve as Chair of Pediatrics at The Ohio State University College of Medicine, pending approval from The Ohio State University Board of Trustees. Dr. Krawczeski will begin this new role in Summer 2022.

Mar 09, 2022

Early Phase Gene Therapy Study for SMARD1/CMT2S Disease Now Enrolling

Nationwide Children's Hospital has launched a new Phase I/IIa gene replacement clinical study to evaluate the safety of a gene therapy for IGHMBP2-related diseases, specifically spinal muscular atrophy with respiratory distress type 1 (SMARD1) and Charcot Marie Tooth disease type 2S (CMT2S). SMARD1 and CMT2S are rare inherited conditions that are both caused by mutations in the IGHMBP2 gene, of which more than 60 have been found to date. SMARD1 is the most severe form of these diseases and causes muscle weakness and respiratory failure in infancy.

Dennis Durbin, MD, MSCE, Named President of the Abigail Wexner Research Institute at Nationwide Children’s Hospital
Feb 25, 2022

Dennis Durbin, MD, MSCE, Named President of the Abigail Wexner Research Institute at Nationwide Children’s Hospital

Beginning March 1, 2022, Dennis Durbin, MD, MSCE, will become the third president of the Abigail Wexner Research Institute at Nationwide Children's Hospital. Dr. Durbin joined Nationwide Children's in 2018 as its first chief scientific officer.

New Study Finds High-Powered Magnets Lead to Hospitalizations and Life-Threatening Injuries in Children
Feb 03, 2022

New Study Finds High-Powered Magnets Lead to Hospitalizations and Life-Threatening Injuries in Children

A recent study led by researchers at the Center for Injury Research and Policy and Emergency Medicine at Nationwide Children’s Hospital along with 24 other children’s hospitals across the country looked at nearly 600 cases of high-powered magnet-related injuries in the three years after high-powered magnets re-entered the US market (2017 to 2019).

Feb 01, 2022

Study supports virotherapy as a potential treatment for brain tumors

A new study provides additional evidence of the efficacy of virotherapy for glioblastoma, the most deadly type of brain tumor. The research findings, published Feb. 1, 2022, in Clinical Cancer Research, indicate that an oncolytic herpes simplex virus, G207, appears to boost immune response and that this is associated with better overall survival for patients with glioblastoma.

Nationwide Children’s Hospital Researcher Lauren Bakaletz, PhD, Honored by AAAS as Lifetime AAAS Fellow
Jan 26, 2022

Nationwide Children’s Hospital Researcher Lauren Bakaletz, PhD, Honored by AAAS as Lifetime AAAS Fellow

The American Association for the Advancement of Science (AAAS), the world’s largest general scientific society and publisher of the Science family of journals, has elected Lauren Bakaletz, PhD, director of the Center for Microbial Pathogenesis in the Abigail Wexner Research Institute (AWRI) at Nationwide Children’s Hospital to the newest class of AAAS Fellows, among the most distinct honors within the scientific community.

Jan 04, 2022

Nationwide Children’s Hospital Expands Diversity and Health Equity Team

Nationwide Children’s Office of Diversity and Health Equity expanded its team to include two additional physician-leaders, Dr. Valencia P. Walker and Dr. Ray Bignall. They join Dr. Olivia Thomas, Chief Diversity and Equity Officer.

Dec 16, 2021

Nationwide Children’s Hospital Receives $50,000 Donation from Mom of Two Young Adults, to Help Support Signs of Suicide® and Big Lots Behavioral Health Services Mood and Anxiety Program

Nationwide Children’s Hospital today announced a $50,000 gift from Maureen Considine Gharrity, Founding Director of Quinn’s Memorial Foundation and Erinn’s Grace Foundation both created to honor her two children, as a gift as well as philanthropic efforts.